These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16343383)

  • 1. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
    Overbosch D; Peyron F; Picot N; Varichon JP; Dumas R; Chambonneau L; Weber F
    J Travel Med; 2005; 12(6):319-26. PubMed ID: 16343383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
    Beeching NJ; Clarke PD; Kitchin NR; Pirmohamed J; Veitch K; Weber F
    Vaccine; 2004 Nov; 23(1):29-35. PubMed ID: 15519704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults.
    Loebermann M; Kollaritsch H; Ziegler T; Rendi-Wagner P; Chambonneau L; Dumas R; Lafrenz M
    Clin Ther; 2004 Jul; 26(7):1084-91. PubMed ID: 15336473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity.
    Proell S; Maiwald H; Nothdurft HD; Saenger R; Vollmar J; De Clercq N; von Sonnenburg F
    J Travel Med; 2002; 9(3):122-6. PubMed ID: 12088576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults.
    Beran J; Chlibek R; Weber F
    Vaccine; 2003 Dec; 21(32):4650-4. PubMed ID: 14585671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
    Proell S
    BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
    [No Abstract]   [Full Text] [Related]  

  • 7. Interchangeability of Hepatitis A boosters, Avaxim and Vaqta, in healthy adults following a primary dose of the combined typhoid/Hepatitis A vaccine Viatim.
    Ekwall E; Ulgemo A; Watson M; Boisnard F; Thomas S; Goullet F
    Vaccine; 2006 May; 24(20):4450-7. PubMed ID: 16621186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
    Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
    Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
    J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study.
    Lau CL; Streeton CL; David MC; Sly PD; Mills DJ
    J Travel Med; 2016 Feb; 23(2):tav023. PubMed ID: 26883924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
    Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
    J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
    Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
    Miyazu M; Kikuchi H; Hamada A; Fukushima S; Ouchi K; Bosch Castells V; Mihara H; Bonnet MC
    Vaccine; 2015 Nov; 33(48):6697-702. PubMed ID: 26518404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever.
    Cartee RT; Thanawastien A; Griffin Iv TJ; Mekalanos JJ; Bart S; Killeen KP
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007912. PubMed ID: 31905228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant vaccination against hepatitis A and typhoid fever.
    Van Hoecke C; Lebacq E; Beran J; Prymula R; Collard F
    J Travel Med; 1998 Sep; 5(3):116-20. PubMed ID: 9772328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
    Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
    Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.